What does Apotheek Gorissen do?

Apotheek Gorissen is a logistics company in Zonhoven. Public Limited, started on 10 December 1987, 1 establishment.

What is the address of Apotheek Gorissen?

The registered office of Apotheek Gorissen is located at Halveweg 68, 3520 Zonhoven.

Is Apotheek Gorissen still active?

Yes. According to the CBE (29 October 2026) Apotheek Gorissen is active, legal situation “Normale toestand”, started on 10 December 1987.

Is Apotheek Gorissen registered on Peppol?

Yes, Apotheek Gorissen is registered on the Peppol network with ID 0208:0432724621.

What is the enterprise number of Apotheek Gorissen?

The enterprise number of Apotheek Gorissen is BE0432724621.

When was Apotheek Gorissen founded?

Apotheek Gorissen was founded on 10 December 1987.

Who are the directors of Apotheek Gorissen?

According to the 2025 annual accounts, the directors of Apotheek Gorissen are: GOFRAN BV.

Is Apotheek Gorissen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 December 1987; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Gorissen make in 2025?

Apotheek Gorissen posted a profit after taxes of € 192,602 in financial year 2025.

What is the revenue of Apotheek Gorissen?

As a small company, Apotheek Gorissen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 385,040.

How much does an employee at Apotheek Gorissen earn?

The average wage cost per full-time employee at Apotheek Gorissen was € 76,400 in 2025: staff costs of € 114,586 for 1.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Gorissen have?

According to the 2025 annual accounts, Apotheek Gorissen has 1.5 full-time equivalents (FTE).

Apotheek Gorissen (Public Limited) - Zonhoven

Dossier Apotheek Gorissen, printed on 29 October 2026 from databakkes.be/en/0432724621/apotheek-gorissen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Apotheek Gorissen from Zonhoven, company number BE0432724621, closed financial year 2025 with a result of € 192,602 after tax. For that financial year Apotheek Gorissen recorded a gross margin of € 385,040 and equity of € 255,478. Compared with financial year 2024, the result moved from € 214,683 to € 192,602. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 255,478

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 192,602

▼ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 331,700

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 192,600 paid out

100 % of the profit went to the shareholders, mostly to GOFRAN (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.5

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 114,586

▲ 7% vs 2024

€ 76,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 9,343

▲ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 75,222

▼ 32% vs 2024

€ 39,216 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 98,104

▲ 19% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 21,727

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 293,533 Gross margin 2022: € 293,533 First fiscal year in the series	€ 325,571 Gross margin 2023: € 325,571 ▲ 11% vs 2022 (€ 293,533) Favourable step	€ 387,476 Gross margin 2024: € 387,476 ▲ 19% vs 2023 (€ 325,571) Favourable step	€ 385,040 Gross margin 2025: € 385,040 ▼ 1% vs 2024 (€ 387,476) Unfavourable step	▼ 1%
Profit after taxes	€ 188,378 Profit after taxes 2022: € 188,378 First fiscal year in the series	€ 188,226 Profit after taxes 2023: € 188,226 Unchanged (€ 188,378) Unfavourable step	€ 214,683 Profit after taxes 2024: € 214,683 ▲ 14% vs 2023 (€ 188,226) Favourable step	€ 192,602 Profit after taxes 2025: € 192,602 ▼ 10% vs 2024 (€ 214,683) Unfavourable step	▼ 10%
Equity	€ 255,367 Equity 2022: € 255,367 First fiscal year in the series	€ 255,392 Equity 2023: € 255,392 Unchanged (€ 255,367) Favourable step	€ 255,475 Equity 2024: € 255,475 Unchanged (€ 255,392) Favourable step	€ 255,478 Equity 2025: € 255,478 Unchanged (€ 255,475) Favourable step
Total debts	€ 825,309 Total debts 2022: € 825,309 First fiscal year in the series	€ 886,089 Total debts 2023: € 886,089 ▲ 7% vs 2022 (€ 825,309) Unfavourable step	€ 978,324 Total debts 2024: € 978,324 ▲ 10% vs 2023 (€ 886,089) Unfavourable step	€ 1,081,869 Total debts 2025: € 1,081,869 ▲ 11% vs 2024 (€ 978,324) Unfavourable step	▲ 11%
Cash	€ 243,589 Cash 2022: € 243,589 First fiscal year in the series	€ 256,103 Cash 2023: € 256,103 ▲ 5% vs 2022 (€ 243,589) Favourable step	€ 307,469 Cash 2024: € 307,469 ▲ 20% vs 2023 (€ 256,103) Favourable step	€ 331,700 Cash 2025: € 331,700 ▲ 8% vs 2024 (€ 307,469) Favourable step	▲ 8%
Land & buildings	€ 260,760 Land & buildings 2022: € 260,760 First fiscal year in the series	€ 242,915 Land & buildings 2023: € 242,915 ▼ 7% vs 2022 (€ 260,760) Unchanged	€ 225,070 Land & buildings 2024: € 225,070 ▼ 7% vs 2023 (€ 242,915) Unchanged	€ 222,970 Land & buildings 2025: € 222,970 ▼ 1% vs 2024 (€ 225,070) Unchanged	▼ 1%
Retained profit	€ 193,367 Retained profit 2022: € 193,367 First fiscal year in the series	€ 193,392 Retained profit 2023: € 193,392 Unchanged (€ 193,367) Favourable step	€ 193,475 Retained profit 2024: € 193,475 Unchanged (€ 193,392) Favourable step	€ 193,478 Retained profit 2025: € 193,478 Unchanged (€ 193,475) Favourable step
Dividend	€ 188,300 Dividend 2022: € 188,300 First fiscal year in the series	€ 188,200 Dividend 2023: € 188,200 Unchanged (€ 188,300) Unchanged	€ 214,600 Dividend 2024: € 214,600 ▲ 14% vs 2023 (€ 188,200) Unchanged	€ 192,600 Dividend 2025: € 192,600 ▼ 10% vs 2024 (€ 214,600) Unchanged	▼ 10%
Bank debt	€ 179,174 Bank debt 2022: € 179,174 First fiscal year in the series	€ 133,910 Bank debt 2023: € 133,910 ▼ 25% vs 2022 (€ 179,174) Favourable step	€ 110,330 Bank debt 2024: € 110,330 ▼ 18% vs 2023 (€ 133,910) Favourable step	€ 75,222 Bank debt 2025: € 75,222 ▼ 32% vs 2024 (€ 110,330) Favourable step	▼ 32%
Balance sheet total	€ 1,080,676 Balance sheet total 2022: € 1,080,676 First fiscal year in the series	€ 1,141,481 Balance sheet total 2023: € 1,141,481 ▲ 6% vs 2022 (€ 1,080,676) Unchanged	€ 1,233,800 Balance sheet total 2024: € 1,233,800 ▲ 8% vs 2023 (€ 1,141,481) Unchanged	€ 1,337,346 Balance sheet total 2025: € 1,337,346 ▲ 8% vs 2024 (€ 1,233,800) Unchanged	▲ 8%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	-	1.5 Employees (FTE) 2024: 1.5 First fiscal year in the series	1.5 Employees (FTE) 2025: 1.5 Unchanged (1.5) Unchanged

Key figures of Apotheek Gorissen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Gorissen?

What happened at Apotheek Gorissen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 192,602 (▼ 10% vs 2024). Source: NBB ↗
2007 GOFRAN BV became a director. NBB
Dec 23, 1987 New establishment in Zonhoven. KBO
Dec 10, 1987 Start of the company according to the CBE. KBO

In short

From € 188,378 profit in 2022 to € 192,602 profit in 2025.

Paid € 67,622 in corporate taxes since 2022.

Best year ever: 2024, with € 214,683 profit.

On average € 256,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

GOFRAN 99.6%

The stake of GOFRAN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Gorissen

Behind Apotheek Gorissen is GOFRAN BV. The shares are held by GOFRAN (99.6%).

Directors

According to the 2025 annual accounts

GOFRAN BV

Managing director · represented by Frank Gorissen

since 2007

Shareholders

GOFRAN

99.6%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Halveweg 68

3520 Zonhoven

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Silabek

€ -179 gross margin · 2025

GOFRAN same network

€ 136,176 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0432.724.621

VAT number

BE 0432.724.621

Registered office

Halveweg 68, 3520 Zonhoven

Names & denominations

Apotheek Gorissen

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

10 December 1987

Peppol

Active · Active since 28 Aug 2023

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Detailhandel in cosmetica en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Gorissen

Warning lights

Financials

What happened to Apotheek Gorissen?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions